Current perspectives on Guillain-Barre syndrome

Background. This article aims to review recent advances in the etiology, typing, pathogenesis and treatment of Guillain-Barre syndrome (GBS). Data sources: Articles were searched in PubMed with the searching items related with Guillain-Barre syndrome. Results and Conclusion: The commonly identified preceding pathogens have been identified such as Campylobacter jejuni, cytomegalovirus and others. Immunomodulating treatment has been proven to alleviate nerve damage and shorten the progression of the disease. GBS remains a serious disorder with a relatively high disability rate and a mortality, which definitely requires more effective treatment.